Renalytix Reports Second Quarter and First Half Fiscal Year

LONDON and SALT LAKE CITY, March 30, 2023 -- Renalytix plc , an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive... | March 30, 2023

Related Keywords

Illinois , United States , Ireland , London , City Of , United Kingdom , Utah , Florida , Salt Lake City , Texas , New York , Petersburg , Sankt Peterburg , Russia , American , Americans , Peter Denardo , Gary Clarence Shalin Bhamra , James Mccullough , Paul Mcmanus Alice Woodings , Renalytix Ai Inc , Exchange Commission On , Investec Bank , Joslin Diabetes Center Inc , American Society Of Nephrology Kidney Week , Company Kidneyintel , Astrazeneca , European Union , American Association Of Nurse Practitioners Annual Meeting , World Obesity Federation , Pnational Kidney Foundation Spring Clinical Meeting , Community Health , Master Care Coordination Services Agreement , Veterans Administration , Services Revenue , Bonds , Nasdaq , Drug Administration , Company On , Kantaro Biosciences , Joslin Diabetes Technology , Public Company Accounting Oversight Board , Renalytix Ai Limited , Care Coordination Services , National Government Services , Many Of The Company , Company See , Exchange Commission , Revenue Service , Icahn School Of Medicine At Mount Sinai , Davita Inc , Uva Health System , Bio Techne Corporation , Mount Sinai Health System , American Diabetes Association , Astrazeneca The Company , Advisory Services Agreement , Journal Of Primary Care Community Health On , Company Care Coordination Services , Va Medical Centers , Centers For Medicare Medicaid Services , Astrazeneca Pharmaceuticals Lp , Diagnostics Holding Plc , Horizon Europe Grant , Primary Care , American Society , Nephrology Kidney Week , Scientific Session , American Association , Nurse Practitioners Annual Meeting , Wake Forest , Mount Sinai , Call Details , Nominated Adviser , Joint Broker , Nicholas Moore , Nick Moore , Breakthrough Designation , Private Securities Litigation Reform Act , Financial Results , Six Months , Annual Report , Blue Cross Shield , Medicare Advantage , Medicaid Services , Primary Care Community Health , American Journal , Managed Care , Horizon Europe , Mount Sinai Health , New York City , American Depositary , Value Adjustments , Value Adjustment , Currency Gain , Financial Condition , Securities Act , Sarbanes Oxley Act , Astrazeneca Pharmaceuticals , Pharmaceutical Services Revenue , Going Concern , Accounting Standards Codification , Accounting Standards Updates , Financial Accounting Standards Board , Fair Value Option Subsections , Financial Instruments , Icahn School , American Depository Shares , Income Taxes , Jumpstart Our Business Startups Act , Own Equity , Convertible Instruments , Convertible Bonds , Conversion Price , Convertible Bond Investor , Recovered Patients , Internal Revenue Service , Clinical Trial Agreement , Joslin Diabetes Center , Holding Plc , Joslin Agreement , Share Option Plan , Vesting Commencement , Months Ended December , Accounting Bulletin , Share Purchase Plan , Stock Compensation , Black Scholes , Kantaro Operating Agreement , Advisory Agreement , Renalytix Plc Stock Exchange , News , Information , Press Release , End , Salt , Lake , Arch , 023 , Renalytix , Lc , N , Rtificial , Itro , Iagnostics , Ocused , Optimizing , Linical , Management , F , Kidney , Disease , O Rnlx Us75973t1016 ,